Pharmaceutical Care for Asthma Control Improvement (PHARMACI)-Study
Not Applicable
Completed
- Conditions
- Asthma
- Registration Number
- NCT00263159
- Lead Sponsor
- University Ghent
- Brief Summary
The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for asthma patients.
- Detailed Description
The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for asthma patients. Patients will be randomly allocated to the control group (= no input from pharmacist) or intervention group (= with pharmaceutical care at baseline and follow-up visits over 6 months).
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 221
Inclusion Criteria
- Patients with persistent asthma
- Asthma treatment for at least 12 months
- Regular visitors of the participating community pharmacy
Exclusion Criteria
- Severe co-morbidity
- > 10 pack-years smoking history
- Asthma Control Test score < 15 or =25
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method The difference between study groups in the change of asthma control from baseline and follow-up visits after 1, 3 and 6 months
- Secondary Outcome Measures
Name Time Method Peak flow after 3 and 6 months Knowledge of asthma and treatment after 6 months Asthma quality of life questionnaire (AQLQ) after 6 months Therapy adherence Inhalation techniques after 6 months Smoking after 6 months Asthma exacerbations after 6 months General Practitioner (GP) visits, emergency room visits and hospitalisations Working days lost and school days lost
Trial Locations
- Locations (1)
University Hospital Ghent
🇧🇪Ghent, Belgium